These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15569143)

  • 1. Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
    Cull CA; Neil HA; Holman RR
    Diabet Med; 2004 Dec; 21(12):1368-71. PubMed ID: 15569143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antiplatelet therapy in a diabetic outpatient service of a large urban public hospital.
    Bruno A; Grassi G; Dani F; Degiovanni M; Maghenzani G; Pagano G
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):42-6. PubMed ID: 15871850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin for primary prevention in patients with diabetes mellitus.
    Nguyen KX; Marinac JS; Sun C
    Fam Med; 2005 Feb; 37(2):112-7. PubMed ID: 15690251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
    Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
    Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of anti-inflammatory (aspirin and/or statin) therapy on body weight in Type 2 diabetic individuals: EAT, a retrospective study.
    Boaz M; Lisy L; Zandman-Goddard G; Wainstein J
    Diabet Med; 2009 Jul; 26(7):708-13. PubMed ID: 19573120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
    González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
    Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of aspirin use in a Nigerian diabetes outpatient clinic.
    Kolawole BA; Adebayo RA; Aloba OO
    Niger J Med; 2004; 13(4):405-6. PubMed ID: 15523870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN).
    Knopp RH; d'Emden M; Smilde JG; Pocock SJ
    Diabetes Care; 2006 Jul; 29(7):1478-85. PubMed ID: 16801565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin use in middle-aged men with cardiovascular disease: are opportunities being missed?
    McCallum AK; Whincup PH; Morris RW; Thomson A; Walker M; Ebrahim S
    Br J Gen Pract; 1997 Jul; 47(420):417-21. PubMed ID: 9281867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between erectile dysfunction and cardiovascular risk in men with Type 2 diabetes in primary care: it is a matter of age.
    Cleveringa FG; Meulenberg MG; Gorter KJ; van den Donk M; Rutten GE
    J Diabetes Complications; 2009; 23(3):153-9. PubMed ID: 18413203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record.
    Rabinowitz I; Tamir A
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin use among U.S. adults: Behavioral Risk Factor Surveillance System.
    Ajani UA; Ford ES; Greenland KJ; Giles WH; Mokdad AH
    Am J Prev Med; 2006 Jan; 30(1):74-7. PubMed ID: 16414427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which patients should receive aspirin for primary prevention of cardiovascular disease? An economic evaluation.
    Annemans L; Lamotte M; Kubin M; Evers T; Verheugt FW
    Int J Clin Pract; 2006 Sep; 60(9):1129-37. PubMed ID: 16939558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy for primary and secondary prevention in Jordanian patients with diabetes mellitus.
    Bulatova NR; Yousef AM; AbuRuz SM
    Thromb Res; 2007; 121(1):43-50. PubMed ID: 17462716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study.
    Rodriguez BL; Fujimoto WY; Mayer-Davis EJ; Imperatore G; Williams DE; Bell RA; Wadwa RP; Palla SL; Liu LL; Kershnar A; Daniels SR; Linder B
    Diabetes Care; 2006 Aug; 29(8):1891-6. PubMed ID: 16873798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of 10-year coronary heart disease risk in Caribbean type 2 diabetic patients using the UKPDS risk engine.
    Ezenwaka CE; Nwagbara E; Seales D; Okali F; Hussaini S; Raja B; Jones-LeCointe A; Sell H; Avci H; Eckel J
    Int J Cardiol; 2009 Mar; 132(3):348-53. PubMed ID: 18191239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance.
    Abdella NA; Mojiminiyi OA; Moussa MA; Zaki M; Al Mohammedi H; Al Ozairi ES; Al Jebely S
    Diabet Med; 2005 Mar; 22(3):278-85. PubMed ID: 15717875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease risk in subjects with type 2 diabetes mellitus in a population in southern Spain.
    Lahoz-Rallo B; Blanco-Gonzalez M; Casas-Ciria I; Marín-Andrade JA; Mendez-Segovia JC; Moratalla-Rodriguez G; Quintero-Dominguez R; Ramirez-Raya M; Guerrero-Pinedo MJ; Aguilar-Diosdado M
    Diabetes Res Clin Pract; 2007 Jun; 76(3):436-44. PubMed ID: 17064808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.